Ganga Pharmaceuticals Q4 Results
- BSE: 539680
- NSE: -
- ISIN: INE615T01017
- Sector: Biotechnology & Drugs
BSE
13.32
0.00 (0.00%)
0.00 (0.00%)Volume0.00
Updated: Fri 23 May, 2025 | 16:00:03
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹1.33 Cr.(-6.38%)
- Operating Profit₹-0.03 Cr.(72.27%)
- Profit After Tax₹0.06 Cr.(80.81%)
- Operating Margin-2.00%(-74.74%)
Note: Comparison is on YoY basis
Quarterly - Ganga Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | - | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1.35 | - | N/A | 1.33 | -5.54% |
| Depreciation/ Amortization | 0.02 | - | N/A | 0.03 | 9.89% |
| Operating Income | -0.03 | - | N/A | -0.10 | 72.27% |
| Net Income | 0.06 | - | N/A | 0.01 | 80.81% |
| Net Income Before Taxes | 0.03 | - | N/A | 0.01 | -38.32% |
| Other Operating Expenses Total | 0.44 | - | N/A | 0.43 | -3.43% |
| Total Revenue | 1.33 | - | N/A | 1.23 | -6.38% |
| Selling/ General/ Admin Expenses Total | 0.29 | - | N/A | 0.25 | -11.83% |
| Diluted Normalized EPS | 0.07 | - | N/A | 0.02 | 111.10% |